The mineralization, drug release and in vivo bone defect repair properties of calcium phosphates/PLA modified tantalum scaffolds. Issue 13 (21st February 2020)

• Record Type: Journal Article
• Authors: Zhou, Rong; Ni, Hai-Jian; Peng, Jin-Hui; Liu, Ning; Chen, Shu; Shao, Jia-Hua; Fu, Qi-Wei; Liu, Jun-Jian; Chen, Feng; Qian, Qi-Rong
• Is Part Of: RSC advances. Volume 10:Issue 13(2020)
• Page Start: 7708
• Page End: 7717
• Publication Date: 2020-02-21
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c9ra09385k
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Calcium phosphate modified tantalum scaffolds displayed high performance on mineralization, sustained drug release and in vivo bone defect repair. Abstract : Calcium phosphate based biomaterials have been widely studied in biomedical areas. Herein, amorphous calcium phosphate (ACP ) nanospheres and hydroxyapatite (HA ) nanorods were separately prepared and used for coating tantalum (Ta ) scaffolds with a polymer of polylactide (PLA ). We have found that different crystal phases of calcium phosphate coated on Ta scaffolds displayed different effects on the surface morphologies, mineralization and bovine serum albumin (BSA ) release. The ACP-PLA and HA-PLA coated on Ta scaffold were more favorable for in vitro mineralization than bare and PLA coated Ta scaffolds, and resulted in a highly hydrophilic surfaces. Meanwhile, the osteoblast-like cells (MG63) showed favorable properties of adhesion and spreading on both ACP-PLA and HA-PLA coated Ta scaffolds. The ACP-PLA and HA-PLA coated Ta scaffolds showed a high biocompatibility and potential applications for in vivo bone defect repair.